Integral Ad Science (NASDAQ:IAS) PT Lowered to $12.00

Integral Ad Science (NASDAQ:IASFree Report) had its price objective lowered by Barclays from $16.00 to $12.00 in a research report sent to investors on Monday, Benzinga reports. The brokerage currently has an equal weight rating on the stock.

Other research analysts have also recently issued research reports about the company. Bank of America started coverage on Integral Ad Science in a research note on Thursday, January 11th. They issued a buy rating and a $19.00 target price on the stock. Truist Financial cut their price target on shares of Integral Ad Science from $26.00 to $17.00 and set a buy rating for the company in a research report on Wednesday, February 28th. Piper Sandler cut their price target on shares of Integral Ad Science from $20.00 to $18.00 and set an overweight rating for the company in a research report on Wednesday, February 28th. Oppenheimer cut their price target on shares of Integral Ad Science from $25.00 to $20.00 and set an outperform rating for the company in a research report on Wednesday, February 28th. Finally, Raymond James lowered shares of Integral Ad Science from a strong-buy rating to an outperform rating and cut their price target for the company from $20.00 to $16.00 in a research report on Wednesday, February 28th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of Moderate Buy and a consensus price target of $17.58.

Read Our Latest Report on Integral Ad Science

Integral Ad Science Stock Down 2.9 %

IAS opened at $9.10 on Monday. The stock has a market cap of $1.45 billion, a PE ratio of 227.56, a P/E/G ratio of 1.65 and a beta of 1.60. The company has a quick ratio of 3.21, a current ratio of 3.21 and a debt-to-equity ratio of 0.17. Integral Ad Science has a 52 week low of $9.08 and a 52 week high of $20.88. The business’s fifty day simple moving average is $11.42 and its 200 day simple moving average is $13.04.

Integral Ad Science (NASDAQ:IASGet Free Report) last released its earnings results on Tuesday, February 27th. The company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. The business had revenue of $134.30 million for the quarter, compared to analysts’ expectations of $131.27 million. Integral Ad Science had a return on equity of 0.83% and a net margin of 1.53%. The firm’s revenue was up 14.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.07 earnings per share. As a group, research analysts expect that Integral Ad Science will post 0.16 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Integral Ad Science news, CAO Alexis Gil II sold 3,177 shares of the firm’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $10.24, for a total value of $32,532.48. Following the completion of the sale, the chief accounting officer now directly owns 120,195 shares in the company, valued at $1,230,796.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Integral Ad Science news, CFO Tania Secor sold 6,570 shares of the firm’s stock in a transaction that occurred on Wednesday, March 6th. The shares were sold at an average price of $9.71, for a total transaction of $63,794.70. Following the completion of the transaction, the chief financial officer now owns 230,888 shares of the company’s stock, valued at $2,241,922.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Alexis Gil II sold 3,177 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $10.24, for a total transaction of $32,532.48. Following the transaction, the chief accounting officer now directly owns 120,195 shares of the company’s stock, valued at approximately $1,230,796.80. The disclosure for this sale can be found here. Insiders sold 80,195 shares of company stock worth $876,562 over the last three months. Company insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Integral Ad Science

A number of institutional investors and hedge funds have recently made changes to their positions in IAS. JPMorgan Chase & Co. increased its stake in shares of Integral Ad Science by 286.0% during the first quarter. JPMorgan Chase & Co. now owns 119,294 shares of the company’s stock valued at $1,646,000 after purchasing an additional 88,390 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of Integral Ad Science by 74.3% during the first quarter. Bank of New York Mellon Corp now owns 87,728 shares of the company’s stock valued at $1,210,000 after acquiring an additional 37,393 shares in the last quarter. Bank of Montreal Can increased its position in shares of Integral Ad Science by 3.5% during the first quarter. Bank of Montreal Can now owns 149,859 shares of the company’s stock valued at $2,155,000 after acquiring an additional 5,018 shares in the last quarter. MetLife Investment Management LLC increased its position in shares of Integral Ad Science by 185.3% during the first quarter. MetLife Investment Management LLC now owns 19,760 shares of the company’s stock valued at $273,000 after acquiring an additional 12,835 shares in the last quarter. Finally, Rhumbline Advisers increased its position in shares of Integral Ad Science by 112.4% during the first quarter. Rhumbline Advisers now owns 33,014 shares of the company’s stock valued at $456,000 after acquiring an additional 17,470 shares in the last quarter. Institutional investors own 95.78% of the company’s stock.

Integral Ad Science Company Profile

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Recommended Stories

Analyst Recommendations for Integral Ad Science (NASDAQ:IAS)

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.